F

Fennec Pharmaceuticals
D

FENC

6.04000
USD
0.40
(7.09%)
مغلق
حجم التداول
2,165
الربح لكل سهم
0
العائد الربحي
-
P/E
-151
حجم السوق
165,690,693
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.09500
    (-1.60%)
    5.85500 USD
    A
    ABIO
    0
    (0%)
    0.000000 USD
    A
    ABUS
    0.01000
    (0.28%)
    3.64000 USD
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRS
    -0.14500
    (-6.62%)
    2.04500 USD
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ASRT
    -0.03000
    (-3.57%)
    0.81000 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.